An Indian pharma wanted to expand their portfolio covering nutrition for mental health in children.
Nutrify Gene : Idea to commercialization was engaged to find a solution for the company’s requirement and came up with 3 place holder opportunities in the spectrum of mental health for children. Nutrify Gene team urged the company to run a trial using the desired strain which resulted in launching India’s first single strain probiotics for mental health in children.
The management was swift to engage solution providers to shorten time which was an issue due to capacity deficit in children nutrition.
They had been meeting multiple contract manufacturers in nutraceuticals and the biggest challenge that was posed to all contract manufacturers and application labs was- single ingredient, single strain-based claims. This required deep study of each botanical, its characteristics, and clinical data.
Solution :
Nutrify Gene : Idea to commercialization through managed intelligence harvesting solution was engaged to find a solution to a precision requirement put up by the pharmaceutical company. Validated claim from single strain or plant in child nutrition in mental health.
On working on Nutrify Gene by senior experts in nutraceuticals, we came up with 3 place holder opportunities in spectrum of mental health for children:
- Cognition
- ADHD
- Anxiety management
Nutrify Gene team ran a unique algorithm to trace out most potential candidates to meet the technical requirement.
The platform presented over 12 options of which two probiotic strains got featured.
The medical screening using the platform and our medical affairs professionals revealed 2 ingredients from plant source and a strain of probiotic from Taiwan best matched the bill.
Taking benchmark of the platform suggestions, our team ran characteristics matching search and came out with two plant ingredients from Indian origin and one probiotic strain that matched all characteristics of strain from Taiwan. A deep analysis of intelligence harvesting produced clinical papers directing the outcome associated with finalized ingredient and alternate strain available in India.
Nutrify Gene team proposed three products in capsule and in symbiotic stick and strongly urged the company to run a proof-of-concept trial on the single probiotic strain available in India to prove the mental health outcome in children. The data points were compelling enough for the pharma company to initiate a trial and as expected the strain matched the outcome desired by the company. The company went ahead and launched India’s first single strain probiotics for mental health for children. The company also went ahead with single ingredient approach to addressing health outcome a very API-ANI like approach. A strong science story backed by the power of Managed Intelligence Harvesting- Nutrify Gene
